Brief: Scilex Pharmaceuticals Enters Into Term Sheet With Virpax Pharmaceuticals
26/02/2024 22:34
Feb 26 (Reuters) - Scilex Holding Co SCLX.O :
* SCILEX HOLDING COMPANY’S WHOLLY OWNED SUBSIDIARY, SCILEX
PHARMACEUTICALS INC., ENTERS INTO A TERM SHEET WITH VIRPAX
PHARMACEUTICALS, INC. REGARDING A MUTUAL RELEASE AND SETTLEMENT
AGREEMENT
* SCILEX HOLDING CO - PARTIES AGREED TO ENTER DEFINITIVE
SETTLEMENT AGREEMENT BY OR BEFORE MARCH 1, 2024 TO RESOLVE
ONGOING DISPUTES
* SCILEX HOLDING CO - SETTLEMENT AGREEMENT RELATES TO
ACTION
FILED BY SCILEX PHARMA, SORRENTO AGAINST ANTHONY MACK AND VIRPAX
Source text for Eikon: ID:nGNX43LVnc
Further company coverage: SCLX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Scilex Holding
See all newsEnters Promissory Note With Vivasor For Revolving Credit Up To $20 Million, On Aug 8
Brief: Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens To List On Biconomy Exchange As Early As June 23, 2026
Brief: O+C Private Credit Wade Defendants Dispute Complaint And Statement By Scilex Holding Company
Company Enters Binding Term Sheet With Datavault Ai - SEC Filing
Company May Offer Up To $500 Million In Securities - SEC Filing